Abstract

The objective of this IAA is to facilitate the development of vaccine assays and preventive strategies for emerging infectious diseases or for organisms that have been used, or have the potential to be used, as agents of bioterrorism.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
NIH Inter-Agency Agreements (Y01)
Project #
Y1AI6153-4-0-1
Application #
7902629
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2009
Total Cost
$1,406,814
Indirect Cost

  Institution

Name
National Institute of Allergy and Infectious Diseases
Department
Type
DUNS #
City
State
Country
Zip Code